Efficacy and safety of tyrosine kinase inhibitor combination therapy for glioblastoma: a meta-analysis with trial sequential analysis of randomized controlled trials
{{output}}
Background: Tyrosine kinase inhibitors (TKIs) administered as monotherapy have demonstrated limited clinical efficacy in glioblastoma (GBM). This study synthesized evidence from existing randomized controlled trials (RCTs) to eva... ...
